BGN and esophageal squamous cell carcinoma: Specifically, we investigated whether CAF-derived BGN contributes to ESCC progression, the intracellular signaling cascades activated by BGN and its interaction with TLR4, as well as its potential effects on other stromal constituents, including fibroblasts and macrophages.